XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E953. A total of 3 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -29.0% | 12,000 | -0.8% | 0.00% | – |
| Q2 2023 | $31 | +1450.0% | 12,100 | +572.2% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 1,800 | -5.3% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 1,900 | +58.3% | 0.00% | – |
| Q3 2022 | $1,000 | -97.1% | 1,200 | -94.8% | 0.00% | – |
| Q2 2022 | $35,000 | +600.0% | 23,200 | +908.7% | 0.00% | – |
| Q1 2022 | $5,000 | -98.7% | 2,300 | -98.2% | 0.00% | – |
| Q4 2021 | $374,000 | – | 127,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,500 | $7,335 | 0.00% |
| SIMPLEX TRADING, LLC | 1,800 | $2 | 0.00% |